Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VRTX vs GSK✓SelectedUSD · GSKVRTX vs GSK performance historyLatest closeAs of-1.08%11/20
Stock and ETF performance explorer

VRTX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+478.3%
GSK return
+97.4%
Excess return
+380.9%
Maximum drawdown
-41.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.1%-0.1%-1.0%-1.0%
7D-4.4%-5.3%+1.0%-1.9%
30D-1.8%-3.7%+1.8%-0.2%
3M-4.7%-7.3%+2.6%-1.4%
6M+19.6%-4.2%+23.9%+21.8%
YTD+13.6%+0.9%+12.7%+12.2%
1Y+22.0%+7.3%+14.7%+17.0%
3Y+44.3%+52.7%-8.4%+12.7%
5Y+181.6%+40.1%+141.5%+125.5%
All+478.3%+97.4%+380.9%+266.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling